论文信息 - A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer - 字舞流文

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer

D. Spriggs | R. Brentjens | R. O’Cearbhaill | M. Koneru | Swati Pendharkar | Mythili Koneru